Grunfeld C, Kotler DP, Shigenaga JK.
et al. Circulating interferon-alpha levels and hypertriglyceridemia in the
acquired immunodeficiency syndrome. Am J Med.1991;90:154-162.
Grunfeld C, Pang M, Doerrler W.
et al. Lipids, lipoproteins, triglyceride clearance, and cytokines in human
immunodeficiency virus infection and the acquired immunodeficiency syndrome. J Clin Endocrinol Metab.1992;74:1045-1052.
Grunfeld C, Feingold KR. Metabolic disturbances and wasting in the acquired immunodeficiency
syndrome. N Engl J Med.1992;327:329-337.
Shor-Posner G, Basit A, Lu Y.
et al. Hypocholesterolemia is associated with immune dysfunction in early
human immunodeficiency virus-1 infection. Am J Med.1993;94:515-519.
Carr A, Samaras K, Burton S.
et al. A syndrome of peripheral lipodystrophy, hyperlipidaemia and insulin
resistance in patients receiving HIV protease inhibitors. AIDS.1998;12:F51-F58.
Behrens G, Dejam A, Schmidt H.
et al. Impaired glucose tolerance, beta cell function and lipid metabolism
in HIV patients under treatment with protease inhibitors. AIDS.1999;13:F63-F70.
Berthold HK, Parhofer KG, Ritter MM.
et al. Influence of protease inhibitor therapy on lipoprotein metabolism. J Intern Med.1999;246:567-575.
Carr A, Samaras K, Thorisdottir A.
et al. Diagnosis, prediction, and natural course of HIV-1 protease-inhibitor-associated
lipodystrophy, hyperlipidaemia, and diabetes mellitus. Lancet.1999;353:2093-2099.
Dong KL, Bausserman LL, Flynn MM.
et al. Changes in body habitus and serum lipid abnormalities in HIV-positive
women on highly active antiretroviral therapy (HAART). J Acquir Immune Defic Syndr.1999;21:107-113.
Periard D, Telenti A, Sudre P.
et al. Atherogenic dyslipidemia in HIV-infected individuals treated with protease
Roberts AD, Muesing RA, Parenti DM.
et al. Alterations in serum levels of lipids and lipoproteins with indinavir
therapy for human immunodeficiency virus-infected patients. Clin Infect Dis.1999;29:441-443.
Bonnet F, Saves M, Droz C.
et al. Increase of atherogenic plasma profile in HIV-infected patients treated
with protease inhibitor-containing regimens. J Acquir Immune Defic Syndr.2000;25:199-200.
Mulligan K, Grunfeld C, Tai VW.
et al. Hyperlipidemia and insulin resistance are induced by protease inhibitors
independent of changes in body composition in patients with HIV infection. J Acquir Immune Defic Syndr.2000;23:35-43.
Henry K, Melroe H, Huebsch J.
et al. Severe premature coronary artery disease with protease inhibitors [letter]. Lancet.1998;351:1328.
Bozzette SA, Ake CF, Tam HK.
et al. Cardiovascular and cerebrovascular events in patients treated for human
immunodeficiency virus infection. N Engl J Med.2003;348:702-710.
Friis-Møller F, Weber R, D'Arminio Monforte A.
et al. Exposure to HAART is associated with an increased risk of myocardial
infarction. Presented at: 10th Conference on Retroviruses and Opportunistic Infections;
February 10-14, 2003; Boston, Mass. Abstract 130.
Staszewski S, Gallant JE, Pozniak AL.
et al. Efficacy and safety of tenofovir DF vs stavudine when used in combination
with lamivudine and efavirenz in antiretroviral naïve patients. Presented at: 10th Conference on Retroviruses and Opportunistic Infections;
February 10-14, 2003; Boston, Mass. Abstract 564b.
Henry K, Melroe H, Huebesch J.
et al. Atorvastatin and gemfibrozil for protease-inhibitor-related lipid abnormalities
Allain CC, Poon LS, Chan CSG.
et al. Enzymatic determination of total serum cholesterol. Clin Chem.1974;20:470-475.
Warnick GR, Albers JJ. A comprehensive evaluation of heparin-manganese precipitation procedure
for estimating high density lipoprotein cholesterol. J Lipid Res.1978;19:65-76.
Rifai N, Iannotti E, DeAngelis K, Law T. Analytical and clinical performance of a homogeneous enzymatic LDL-cholesterol
assay compared with the ultracentrifugation-dextran sulfate-Mg2+ method. Clin Chem.1998;44:1242-1250.
Giorgi JV, Cheng HL, Margolick JB.
et al. Quality control in the flow cytometric measurement of T-lymphocyte
subsets. Clin Immunol Immunopathol.1990;55:173-186.
US Department of Health and Human Services, National Center for
Health Statistics. Third National Health and Nutrition Examination Survey,
1998-1999 Public Use Data File [CD-ROM]. Hyattsville, Md: Centers for Disease Control and Prevention; 1996.
Johnson CL, Rifkind BM, Sempos CT.
et al. Declining serum total cholesterol levels among US adults. JAMA.1993;269:3002-3008.
Not Available. Executive Summary of the Third Report of the National Cholesterol Education
Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High
Blood Cholesterol in Adults (Adult Treatment Panel III). JAMA.2001;285:2486-2497.